CNBC Pro

BMO initiates Pfizer at outperform, says Covid drugs and strong pipeline will boost pharma stock

A person walks past the Pfizer Headquarters building in New York, December 7, 2020.
Carlo Allegri | Reuters

The trend of strong drug development and stock outperformance should continue for Pfizer, making it a smart bet for investors, according to BMO Capital Markets.

More In Street Calls

This little-known lithium stock is set to surge more than 60% next year, Cowen predicts
CNBC ProThis little-known lithium stock is set to surge more than 60% next year, Cowen predicts
Wolfe Research downgrades travel stocks, says demand likely to slow as economic headwinds pick up
CNBC ProWolfe Research downgrades travel stocks, says demand likely to slow as economic headwinds pick up
Top media analyst from Bank of America names the best value stock in the sector
CNBC ProTop media analyst from Bank of America names the best value stock in the sector